Ocular and neurologic involvement of FIP is seen more frequently in its noneffusive (ie, dry) form and occurs in up to 36% of cases. FIP can be treated with GS-441524; data, however, are limited regarding use of GS-441524 or remdesivir for treatment of ocular forms of FIP.